Abu Dhabi Stem Cells Center Successfully Manufactures UAE's First CAR-T Cell to Treat an 11-Year Old Leukemia Patient
ABU DHABI, UAE, Sept. 18, 2023 /PRNewswire/ -- Abu Dhabi Stem Cells Center (ADSCC), a PureHealth subsidiary and the largest healthcare platform in the Middle East, has successfully manufactured the UAE's first CAR-T cells to treat an 11-year-old boy with leukemia.
- ABU DHABI, UAE, Sept. 18, 2023 /PRNewswire/ -- Abu Dhabi Stem Cells Center (ADSCC), a PureHealth subsidiary and the largest healthcare platform in the Middle East, has successfully manufactured the UAE's first CAR-T cells to treat an 11-year-old boy with leukemia.
- The child, Murad, was diagnosed with leukemia more than five years ago and went into remission, but unfortunately, the leukemia returned approximately six months ago.
- The treatment took five weeks, during which Murad was admitted at ADSCC, the only accredited Centre of Excellence in Hematopoietic Stem Cell Transplantation in Abu Dhabi.
- Physicians withdrew the cells from the patient and genetically modified his immune cells in the laboratory to fight the cancer cells after intravenously injecting them into the patient.